Analyst Ratings for Regeneron Pharma (REGN) [Buys]
REGN Rating Summary
REGN Price Target Summary
- Highest: $1,189.00 (RBC Capital)
- Lowest: $720.00 (BofA Securities)
- Average: $1,028.53
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1,028.53 (+14.1%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$1,028.53 (+14.1%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/12/2024 | Bernstein SocGen Group | William Pickering | New Coverage | Outperform (N/A) |
1,125.00 (N/A) |
968.83 (901.19) |
-6.98% | Details |
| 1/12/2024 | RBC Capital » Updated 4/11/2024 |
Brian Abrahams | Upgrade | Outperform (Sector Perform) |
1,189.00 (N/A) |
915.97 (901.19) |
-1.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
